Suppr超能文献

用于食品生产动物抗生素耐药性长期管理的风险分析框架。

A risk analysis framework for the long-term management of antibiotic resistance in food-producing animals.

作者信息

Salisbury Janet G, Nicholls Terence J, Lammerding Anna M, Turnidge John, Nunn Michael J

机构信息

Biotext, 113 Hopetoun Circuit, Yarralumla, ACT 2600, Australia.

出版信息

Int J Antimicrob Agents. 2002 Sep;20(3):153-64. doi: 10.1016/s0924-8579(02)00169-3.

Abstract

In recent years, there has been increasing concern that the use of antibiotics in food-producing animals, particularly their long-term use for growth promotion, contributes to the emergence of antibiotic-resistant bacteria in animals. These resistant bacteria may spread from animals to humans via the food chain. They may also transfer their antibiotic-resistance genes into human pathogenic bacteria, leading to failure of antibiotic treatment for some, possibly life-threatening, human conditions. To assist regulatory decision making, the actual risk to human health from antibiotic use in animals needs to be determined (risk assessment) and the requirements for risk minimisation (risk management and risk communication) determined. We propose a novel method of risk analysis involving risk assessment for three interrelated hazards: the antibiotic (chemical agent), the antibiotic-resistant bacterium (microbiological agent) and the antibiotic-resistance gene (genetic agent). Risk minimisation may then include control of antibiotic use and/or the reduction of the spread of bacterial infection and/or prevention of transfer of resistance determinants between bacterial populations.

摘要

近年来,人们越来越担心在食用动物中使用抗生素,尤其是长期将其用于促进生长,会导致动物体内出现抗生素耐药菌。这些耐药菌可能通过食物链从动物传播给人类。它们还可能将其抗生素耐药基因转移到人类病原菌中,导致一些可能危及生命的人类疾病的抗生素治疗失败。为协助监管决策,需要确定动物使用抗生素对人类健康的实际风险(风险评估),并确定风险最小化的要求(风险管理和风险沟通)。我们提出了一种新的风险分析方法,涉及对三种相互关联的危害进行风险评估:抗生素(化学制剂)、抗生素耐药菌(微生物制剂)和抗生素耐药基因(遗传制剂)。然后,风险最小化可能包括控制抗生素的使用和/或减少细菌感染的传播和/或防止耐药决定簇在细菌群体之间转移。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验